Massivemarkets

AVIR

Atea Pharmaceuticals, Inc. Common Stock

Nasdaq · usd

$3.98+0.05 (+1.27%)
As of 2:25:56 PM EST on Nov 20, 2026 · 15-minute delayed

Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $3.98 (+1.27%) as of 2:25:56 PM EST on Nov 20, 2026, -1.73% over the past month. Market cap is $315.6M, with 9.6 days to cover in short interest.

Stock performance

How Atea Pharmaceuticals, Inc. Common Stock (AVIR) stock has performed from one day to one year, with its 52-week range.

+0.25%
+$0.01 over 1D
$3.88$3.91$3.95$3.999:30 AM10:45 AM11:55 AM1:10 PM2:25 PM$3.98
1D
+1.27%
1W
-7.44%
1M
-1.73%
YTD
+11.48%
1Y
+34.01%
52-wk range
$2.93 – $6.45

Key statistics

Today's trading snapshot for AVIR: day range, open, previous close, volume and market cap.

Day range
$3.80 – $4.01
Open
$3.88
Prev close
$3.93
Volume
168.62K
Market cap
$315.6M
Shares out
80.3M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Atea Pharmaceuticals, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
—
P/B
1.80
P/FCF
—
ROE
-88.5%
ROA
-77.4%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 19, 2026

8-K filings

Material corporate events Atea Pharmaceuticals, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On November 9, 2026, Atea Pharmaceuticals, Inc. issued a press release announcing its financial results for the three months ended September 30, 2026.

  • Credit facilityNov 9, 2026

    On November 6, 2026 (the "Closing Date"), Atea Pharmaceuticals, Inc. entered into a Loan and Security Agreement with Hercules Capital, Inc., as agent, and the lenders party thereto, providing for term loans in an aggregate principal amount of up to $200.0 million. The Agreement provides for senior secured term loans maturing on November 1, 2031.

  • On January 8, 2026, Atea Pharmaceuticals, Inc. (the "Company") issued a press release announcing, among other things, the Company's preliminary unaudited cash and investment balance as of December 31, 2025.

  • Annual meeting resultsJun 20, 2025

    On June 20, 2025, Atea Pharmaceuticals, Inc. held its 2025 Annual Meeting of Stockholders. Based upon the foregoing votes, Bruno Lucidi, Dr. Polly Murphy and Dr. Bruce Polsky were elected as Class II directors and Proposals 2 and 3 were approved.

  • Director departureApr 17, 2025

    Franklin Berger will not stand for reelection to the Board as a Class I director when his term expires at the Company's 2027 annual meeting of stockholders. Franklin Berger informed the Board that he would retire following the end of his current term as a Class I director at the 2027 Annual Meeting.

Dividend history and stock splits

Atea Pharmaceuticals, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-11Feb 14, 2018

AVIR short interest

How heavily AVIR is shorted: shares short, days to cover and average daily volume.

Days to cover
9.6
Short interest
3.01M
Avg volume
315.09K

As of · reported to FINRA twice monthly.

AVIR news

The latest news and headlines about Atea Pharmaceuticals, Inc. Common Stock (AVIR).

Frequently asked questions

What is the Atea Pharmaceuticals, Inc. Common Stock (AVIR) stock price today?

Atea Pharmaceuticals, Inc. Common Stock (AVIR) is trading at $3.98 (+1.27% on the day) as of 2:25:56 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Atea Pharmaceuticals, Inc. Common Stock?

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases.

What is the short interest in AVIR?

As of Oct 30, 2026, AVIR has 3.01M shares short and 9.6 days to cover.

What exchange is AVIR listed on?

Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of AVIR with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a AVIR analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.